Bank Of New York Mellon Corp Design Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$5.5 - $9.77 $682,291 - $1.21 Million	124,053 New	124,053 $716 Million
Q4 2022 Feb 14, 2023	BUY	$7.86 - $17.2 $994,164 - $2.18 Million	126,484 New	126,484 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $321,576 - $583,584	22,823 Added 22.29%	125,207 $2.09 Million
Q2 2022 Aug 15, 2022	BUY	$9.91 - $17.33 $123,161 - $215,377	12,428 Added 13.82%	102,384 $1.43 Million
Q1 2022 May 11, 2022	BUY	$11.17 - $20.89 $255,212 - $477,294	22,848 Added 34.05%	89,956 $1.45 Million
Q4 2021 Feb 11, 2022	BUY	$13.64 - $21.41 $417,820 - $655,831	30,632 Added 83.98%	67,108 $1.44 Million
Q3 2021 Nov 12, 2021	BUY	$13.99 - $20.03 $41,676 - $59,669	2,979 Added 8.89%	36,476 $536,000
Q2 2021 Aug 11, 2021	BUY	$19.02 - $29.78 $637,112 - $997,540	33,497 New	33,497 $666,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.